{
  "docId": "019de070-3a76-76eb-bdcd-70a194f2629a",
  "docSlug": "3b5651eafaa236908b5aaeea5fdc2dcc",
  "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides",
  "authorId": "aeglea-biotherapeutics",
  "authorName": "Aeglea BioTherapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2020-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 10,
  "pageCount": 28,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "traction",
  "function": "show_traction",
  "density": "balanced",
  "nDataPoints": 10,
  "notes": "The chart shows a box plot progression from baseline to week 56, demonstrating efficacy in reaching target ranges.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-3a76-76eb-bdcd-70a194f2629a/10",
  "deckHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a",
  "deckJsonHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a.json",
  "deckAnchorHref": "/decks/019de070-3a76-76eb-bdcd-70a194f2629a#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.52,
        "x": 0.04,
        "y": 0.27
      },
      "kind": "chart",
      "text": "Plasma Arginine in Response to Pegzilarginase",
      "attrs": null,
      "subkind": "box",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9ce5aed8-3923-4fde-95fc-8cbb17b146d7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.38,
        "x": 0.58,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "Baseline plasma arginine on standard disease management was markedly elevated. Significant and sustained reductions in plasma arginine were achieved from baseline to week 1, week 8, week 20 and week 56. At the week 56 analysis: The median plasma arginine was 99µM (40-115µM). 10/13 patients achieved plasma arginine within normal range (40-115µM). 13/13 patients achieved plasma arginine within target range (<200uM)",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9fb7a33d-38d6-4ad6-9565-f55354b1ea19",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.04,
        "y": 0.07
      },
      "kind": "title",
      "text": "Pegzilarginase Markedly Reduces and Sustainably Controls Plasma Arginine",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "92225e6e-695b-4987-84a5-e57e218c2aa1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}